SPINAL MUSCULAR ATROPHY TYPE 3
Clinical trials for SPINAL MUSCULAR ATROPHY TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new SPINAL MUSCULAR ATROPHY TYPE 3 trials appear
Sign up with your email to follow new studies for SPINAL MUSCULAR ATROPHY TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for SMA babies: drug trial aims to boost motor milestones
Disease control Recruiting nowThis study tests a drug called apitegromab in babies under 2 years old who have spinal muscular atrophy (SMA), a genetic condition that weakens muscles. The goal is to see if the drug can improve motor skills like sitting and crawling. All participants must already be on standard…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Smart insoles could reveal hidden clues in rare muscle diseases
Knowledge-focused Recruiting nowThis study aims to find new ways to measure walking problems in children with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA). About 106 participants will wear special insoles that track their steps and movement during daily activities and in clinic tests. The…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 17, 2026 02:46 UTC
-
Can your walk reveal your bone strength? new study in spinal muscular atrophy aims to find out
Knowledge-focused Recruiting nowThis study looks at how the way people with spinal muscular atrophy (SMA) walk might be linked to their bone health. Researchers will measure walking patterns and bone density in about 22 people aged 8 to 50 who can walk without help. Participants have one clinic visit and short …
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Sponsor: Jacqueline Montes • Aim: Knowledge-focused
Last updated May 17, 2026 02:39 UTC